1 | for vaccine production and | | | | | | | 3 | 0.46% |
2 | vaccine production and innovation | | | | | | | 3 | 0.46% |
3 | production and innovation in | | | | | | | 3 | 0.46% |
4 | centres of excellence initiative | | | | | | | 2 | 0.31% |
5 | the centres of excellence | | | | | | | 2 | 0.31% |
6 | and innovation in africa | | | | | | | 2 | 0.31% |
7 | a centres of excellence | | | | | | | 2 | 0.31% |
8 | offer an indepth analysis | | | | | | | 1 | 0.15% |
9 | assessments offer an indepth | | | | | | | 1 | 0.15% |
10 | an indepth analysis of | | | | | | | 1 | 0.15% |
11 | which are part of | | | | | | | 1 | 0.15% |
12 | companies and new planned | | | | | | | 1 | 0.15% |
13 | gaps assessments offer an | | | | | | | 1 | 0.15% |
14 | technology gaps assessments offer | | | | | | | 1 | 0.15% |
15 | of excellence initiative these | | | | | | | 1 | 0.15% |
16 | of the centres of | | | | | | | 1 | 0.15% |
17 | part of the centres | | | | | | | 1 | 0.15% |
18 | are part of the | | | | | | | 1 | 0.15% |
19 | indepth analysis of existing | | | | | | | 1 | 0.15% |
20 | avpa defaultlogo menu home | | | | | | 1 | 0.15% |
21 | countries which are part | | | | | | | 1 | 0.15% |
22 | makers read more we | | | | | | | 1 | 0.15% |
23 | these questions technical assistancetraining | | | | | | | 1 | 0.15% |
24 | questions technical assistancetraining to | | | | | | | 1 | 0.15% |
25 | technical assistancetraining to african | | | | | | | 1 | 0.15% |
26 | assistancetraining to african firms | | | | | | | 1 | 0.15% |
27 | universities policy makers read | | | | | | | 1 | 0.15% |
28 | policy makers read more | | | | | | | 1 | 0.15% |
29 | read more we conduct | | | | | | | 1 | 0.15% |
30 | production system in select | | | | | | | 1 | 0.15% |
31 | more we conduct technology | | | | | | | 1 | 0.15% |
32 | we conduct technology gaps | | | | | | | 1 | 0.15% |
33 | assessment of the vaccine | | | | | | | 1 | 0.15% |
34 | of the vaccine production | | | | | | | 1 | 0.15% |
35 | the vaccine production system | | | | | | | 1 | 0.15% |
36 | vaccine production system in | | | | | | | 1 | 0.15% |
37 | system in select african | | | | | | | 1 | 0.15% |
38 | and new planned ventures | | | | | | | 1 | 0.15% |
39 | social science scholars to respond | | | | | | | 1 | 0.15% |
40 | assessment of all macro | | | | | | | 1 | 0.15% |